Company intelligence / Profile preview

Grid Biosciences

Kowloon Tong, Hong Konggridbiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Grid Biosciences develops innovative prophylactic and therapeutic vaccines targeting difficult-to-treat infectious diseases, especially those caused by Epstein-Barr virus. Their lead program leverages NIH-developed technology to create a first-in-class vaccine aimed at preventing both acute infection and downstream malignancies or autoimmune sequelae. They have partnered with IVI to advance global access strategies but have not yet reported clinical trial results.

Therapeutic areas: OncologyImmunologyNeurologyInfectious Diseases
Modalities: Prophylactic vaccinesTherapeutic vaccines(General) Vaccines and therapeutics for infectious diseases and related conditions
Industry: Biotech

Drug pipeline

3 assets

influenza vaccine (ferritin vehicle)

Approved

2 more assets in the full pipeline.

Request access →

Partnerships

International Vaccine Institute (IVI)National Institutes of Health (NIH)

Beyond the preview

Go deeper on Grid Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grid Biosciences.

Explore the full profile